Neena M. Patil

2019

In 2019, Neena M. Patil earned a total compensation of $3.2M as Senior Vice President and GC at Jazz Pharmaceuticals.

Compensation breakdown

Bonus$62,500
Non-Equity Incentive Plan$100,000
Option Awards$1,228,737
Salary$166,731
Stock Awards$1,645,439
Other$2,375
Total$3,205,781

Patil received $1.6M in stock awards, accounting for 51% of the total pay in 2019.

Patil also received $62.5K in bonus, $100K in non-equity incentive plan, $1.2M in option awards, $166.7K in salary and $2.4K in other compensation.

Rankings

In 2019, Neena M. Patil's compensation ranked 3,807th out of 13,971 executives tracked by ExecPay. In other words, Patil earned more than 72.8% of executives.

ClassificationRankingPercentile
All
3,807
out of 13,971
73rd
Division
Manufacturing
1,376
out of 5,695
76th
Major group
Chemicals And Allied Products
482
out of 2,194
78th
Industry group
Drugs
406
out of 1,880
78th
Industry
Pharmaceutical Preparations
307
out of 1,392
78th

Pay ratio

Neena M. Patil's Pay$3,205,781
Median Employee's Pay$214,881
Pay Ratio

15

to 1

In 2019, the annual total compensation of Neena M. Patil was $3,205,781.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $214,881.

The ratio of Neena M. Patil's pay to the pay of median employee was therefore 15 to one.

Source: SEC filing on June 12, 2020.

Patil's colleagues

We found six more compensation records of executives who worked with Neena M. Patil at Jazz Pharmaceuticals in 2019.

2019

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2019

Daniel Swisher

Jazz Pharmaceuticals

Chief Operating Officer

2019

Robert Iannone

Jazz Pharmaceuticals

Executive Vice President, Research and Development

2019

Robert Ianonne

Jazz Pharmaceuticals

Chief Medical Officer

2019

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

2019

Matthew Young

Jazz Pharmaceuticals

Chief Financial Officer

News

You may also like